Are we nearly there yet? Starts and stops on the road to use of polygenic scores.

As technological advancements expand the accessibility and availability of molecular genetic data, excitement over the potential use of genetic risk scores also known as polygenic scores (PGS) or polygenic indices for disease prevention has grown. At the same time, however, the translation of PGS into healthcare and social settings raises a host of social, ethical, and clinically relevant questions.